Literature DB >> 17074514

Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells.

Hui Zheng1, Ming Li, Haidan Liu, Wei Ren, Duo-sha Hu, Ying Shi, Ming Tang, Ya Cao.   

Abstract

It is generally believed that under normal conditions only B lymphocytes express immunoglobulin. Interestingly, our previous work demonstrated that epithelial cancer tissues and cancer cell lines also express Ig alpha heavy chain. So we further analyzed the potential function of cancer-derived Ig alpha heavy chain. Here we show that blockade of cancer-derived Ig alpha suppressed the growth and viability of cancer cells. And cancer-derived Ig alpha promotes the malignant proliferation ability of cancer cells. Furthermore, we demonstrated that Ig alpha protein increases the access percentage of S phase from the early mitosis of synchronized cancer cells. Our findings support the important role of cancer-derived Ig alpha as a growth promoter of cancer cells, and reveal a novel molecular mechanism for growth and proliferation of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074514     DOI: 10.1016/j.cellbi.2006.09.009

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  21 in total

1.  AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers.

Authors:  Zhi Duan; Hui Zheng; Haidan Liu; Ming Li; Min Tang; Xinxian Weng; Wei Yi; Ann M Bode; Ya Cao
Journal:  Cell Mol Immunol       Date:  2015-04-06       Impact factor: 11.530

2.  The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination.

Authors:  Baeck-seung Lee; Joseph D Dekker; Bum-kyu Lee; Vishwanath R Iyer; Barry P Sleckman; Arthur L Shaffer; Gregory C Ippolito; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

3.  Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines.

Authors:  Ming Li; Hui Zheng; Zhi Duan; Haidan Liu; Duosha Hu; Ann Bode; Zigang Dong; Ya Cao
Journal:  Cell Mol Immunol       Date:  2011-10-31       Impact factor: 11.530

4.  Heterogeneity of aberrant immunoglobulin expression in cancer cells.

Authors:  Duosha Hu; Zhi Duan; Ming Li; Yiqun Jiang; Haidan Liu; Hui Zheng; Lili Li; Ann M Bode; Zigang Dong; Ya Cao
Journal:  Cell Mol Immunol       Date:  2011-08-22       Impact factor: 11.530

5.  [Effect of androgen receptor on IgG expression, proliferation and migration of prostate cancer cells in vitro].

Authors:  Yu-Lin Deng; Kai Guo; Ying-Ke Zeng; Kai-Hui Wu; Chen Tang; Shao-Bo Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

6.  Evaluation of humoral immunity in oral cancer patients from a nigerian referral centre.

Authors:  Victor I Akinmoladun; Olatubosun G Arinola; T Elumelu-Kupoluyi; Lucy O Eriba
Journal:  J Maxillofac Oral Surg       Date:  2012-09-25

Review 7.  Immunoglobulin expression in non-lymphoid lineage and neoplastic cells.

Authors:  Zhengshan Chen; Xiaoyan Qiu; Jiang Gu
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

8.  Activation of the Ig Iα1 promoter by the transcription factor Ets-1 triggers Ig Iα1-Cα1 germline transcription in epithelial cancer cells.

Authors:  Zhi Duan; Hui Zheng; San Xu; Yiqun Jiang; Haidan Liu; Ming Li; Duosha Hu; Wei Li; Ann M Bode; Zigang Dong; Ya Cao
Journal:  Cell Mol Immunol       Date:  2013-11-04       Impact factor: 11.530

9.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401

10.  IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.

Authors:  Na Niu; Jie Zhang; Tao Huang; Yingui Sun; Zhengshan Chen; Weining Yi; Christine Korteweg; Juping Wang; Jiang Gu
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.